US-based journal Science, published by the American Association for the Advancement of Science (AAAS), has announced plans to launch a new journal on research in translational medicine, which uses insights from basic biology to improve medical care. The journal, Science Translational Medicine, is slated for launch in fall 2009.
Dr. Elias Zerhouni, Senior Fellow at the Bill & Melinda Gates Foundation's Global Health Program and former Director of the U.S. National Institutes of Health, has accepted the position of Chief Scientific Advisor for the journal. Together with the journal's Advisory Board of clinician scientists and other experts, and Editor Katrina L. Kelner, Dr. Zerhouni will set the strategic direction of the journal and work with staff to attract and publish research that represents both excellent science and significant advances for human health.
Science Translational Medicine is being launched to help researchers more efficiently access and apply new findings from many different fields. Specifically, the journal will serve researchers and management in academia, government, and the biotechnology and pharmaceutical industries, physician scientists, regulators, policy-makers, investors, business developers, and funding agencies. The journal will publish original, peer-reviewed, science-based research, including small clinical trials and other studies of human biology, as well research on animal models of human disease. 'Perspective' articles and Reviews will discuss new findings from both a basic science and a clinical point of view. The journal will also feature and synthesise informed commentary on policy, funding, regulatory issues, and more.
Science Translational Medicine will be published weekly online, every Wednesday, and a compilation of selected articles will be offered in a print edition, published monthly.
